Tech Company Financing Transactions
VisCardia Funding Round
VisCardia, operating out of Beaverton, secured $12.5 million from Kinetic Ventures and private investors.
Transaction Overview
Company Name
Announced On
2/3/2017
Transaction Type
Venture Equity
Amount
$12,500,000
Round
Series B
Investors
Kinetic Ventures (Lead Investor)
private investors (Michael Mirro)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8770 SW Nimbus Ave.
Beaverton, OR 97008
USA
Beaverton, OR 97008
USA
Phone
Website
Email Address
Overview
VisCardia was incorporated in 2015 dedicated to commercializing our novel proprietary failure therapy. VisCardia based in Portland, OR is developing a novel implantable device therapy for treating heart failure, a condition that afflicts 10 million patients in the U.S. and Europe.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Bauer
Executive Vice President
Ed Chinchoy
VP - Regulatory Affairs
Gregg Harris
Browse more venture capital transactions:
Prev: 2/3/2017: Vividion Therapeutics venture capital transaction
Next: 2/3/2017: Scytl venture capital transaction
Share this article
About Our VC Transactions Data
We report on funding rounds that are announced publicly. VC investment data records reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs